āĻāĻĒāύāĻžāϰ āϰāĻŋāĻĒā§āϰā§āĻ āĻĒāĻžāĻ āĻžāύ
āĻā§āϰāĻŽ 1
Junctional Epidermolysis Bullosa (JEB) is a rare, inherited skin disorder that causes the skin and mucous membranes to become extremely fragile. Even minor friction or trauma can lead to painful blisters and wounds. This condition is typically evident from birth and can vary in severity. Some forms, such as Herlitz type JEB, are life-threatening in infancy, while others may allow longer-term survival with ongoing care. JEB is caused by genetic mutations affecting proteins vital for skin integrity, leading to separation within the skin layers.
1. Herlitz Junctional Epidermolysis Bullosa (JEB-H):
The most severe form; blisters form soon after birth and affect the skin, airways, and internal linings. Often life-limiting.
2. Non-Herlitz JEB:
Milder forms with longer survival. Blisters may be limited to the skin and oral cavity.
3. Laryngo-onycho-cutaneous Syndrome:
A rare JEB subtype involving the eyes, nails, and airways along with skin symptoms.
Fragile skin that blisters easily, especially in friction-prone areas
Widespread blistering in newborns
Chronic wounds that may get infected
Nail abnormalities or loss of nails
Hair loss in some cases
Breathing difficulties in severe types due to airway blistering
Difficulty swallowing due to internal blistering
Poor weight gain and growth delays
Genetic mutations affecting proteins (like laminin-332) that anchor the skinâs layers.
Inherited in an autosomal recessive pattern (both parents must carry the gene).
Defects in genes such as LAMA3, LAMB3 or LAMC2.
Life-threatening infections from open wounds
Scarring and skin thickening
Severe anemia due to chronic blood loss
Nutritional deficiencies
Airway obstruction in Herlitz JEB
Risk of aggressive skin cancers in adolescence or adulthood
Dental issues due to enamel defects
Family history of epidermolysis bullosa
Consanguineous (closely related) parentage
Genetic carriers of the faulty genes
Genetic counseling before pregnancy for at-risk families.
Prenatal genetic testing (chorionic villus sampling or amniocentesis).
Preimplantation genetic diagnosis (PGD) in IVF to avoid passing on the condition.
āϏā§āĻŦāĻā§āĻ - āĻĒā§āĻļāĻžāĻĻāĻžāϰ - āĻāĻžāĻŽā§āϞāĻž āĻŽā§āĻā§āϤ
āĻāĻĒāύāĻžāϰ āϰāĻŋāĻĒā§āϰā§āĻ āĻĒāĻžāĻ āĻžāύ
āĻā§āϰāĻŽ 1
āĻāĻŋāĻāĻŋā§āϏāĻž āĻĒāϰāĻžāĻŽāϰā§āĻļ āύāĻŋāύ
āĻā§āϰāĻŽ 2
āĻĒā§āϰāĻžāĻ-āĻāĻāĻŽāύ āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāϝāĻŧ āϏāĻšāĻžāϝāĻŧāϤāĻž āĻĒāĻžāύ
āĻā§āϰāĻŽ 3
āĻĒāϰāĻŋāĻŦāĻšāύ āĻāĻŦāĻ āĻāĻŦāĻžāϏāύ āĻŦā§āϝāĻŦāϏā§āĻĨāĻžāĻĒāύāĻžāϝāĻŧ āϏāĻšāĻžāϝāĻŧāϤāĻž
āĻā§āϰāĻŽ 4
āĻāĻŋāĻāĻŋā§āϏāĻž āĻā§āĻĄāĻŧā§ āϏāϰā§āĻŦāϤā§āϰ āϏāĻšāĻžāϝāĻŧāϤāĻž
āĻā§āϰāĻŽ 5
āĻĢāĻŋāϰ⧠āϝāĻžāĻāϝāĻŧāĻžāϰ āĻĒāϰ āĻĢāϞā§āĻāĻĒ
āĻā§āϰāĻŽ 6
āϰā§āĻāĻŋāĻŽā§āύ āĻšā§āϞāĻĨāĻā§āϝāĻŧāĻžāϰ āĻšāϞ āĻļā§āϰā§āώāϏā§āĻĨāĻžāύā§āϝāĻŧ āĻāĻŋāĻāĻŋā§āϏāĻāĻĻā§āϰ āĻā§āύā§āĻĻā§āϰ āĻāĻŦāĻ āĻā§āϏ, āϝāĻžāϰāĻž āϤāĻžāĻĻā§āϰ āĻĻāĻā§āώāϤāĻž āĻ āĻ āĻāĻŋāĻā§āĻāϤāĻžāϰ āĻāύā§āϝ āϏā§āĻĒāϰāĻŋāĻāĻŋāϤ

āϰā§āĻāĻŋāĻŽā§āύ āĻšā§āϞāĻĨāĻā§āϝāĻŧāĻžāϰ āĻšāϞ āĻļā§āϰā§āώāϏā§āĻĨāĻžāύā§āϝāĻŧ āĻāĻŋāĻāĻŋā§āϏāĻāĻĻā§āϰ āĻ āĻŋāĻāĻžāύāĻž āĻāĻŦāĻ āĻā§āϏ, āϝāĻžāϰāĻž āϤāĻžāĻĻā§āϰ āĻĻāĻā§āώāϤāĻž āĻ āĻ āĻāĻŋāĻā§āĻāϤāĻžāϰ āĻāύā§āϝ āϏā§āĻĒāϰāĻŋāĻāĻŋāϤ
āĻŽāĻŋāϏ āĻŽāĻžāϤāϞā§āĻŦāĻž āĻāĻāĻŋāϞā§āĻāĻž
Uzbekistan
āĻāĻāĻŦā§āĻāĻŋāϏā§āϤāĻžāύā§āϰ āĻŽāĻŋāϏ āĻŽāĻžāϤāϞā§āĻŦāĻž āϤāĻžāĻāϰ āύāĻŋāĻ āĻĻā§āĻļā§ āĻāĻāĻžāϧāĻŋāĻ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĻā§āĻŦāĻžāϰāĻž āϞāĻŋāĻāĻžāϰ āϏāĻŋāϰā§āϏāĻŋāϏ āύāĻŋāϰā§āĻŖāϝāĻŧā§āϰ āĻĒāϰ āĻŦāĻŋāώāϝāĻŧāĻāĻŋ āϏāĻŽā§āĻĒāϰā§āĻā§ āϏā§āĻĒāώā§āĻ āϧāĻžāϰāĻŖāĻž āĻĒāĻžāĻāϝāĻŧāĻžāϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠āĻāĻžāϰāϤ⧠āĻāϏā§āύāĨ¤..
āĻŽāĻŋ. āĻĢāϝāĻŧāϏāĻžāϞ āĻāϞ āĻāϤāĻžāĻāĻŦāĻŋ
Saudi Arabia
āϏā§āĻĻāĻŋ āĻāϰāĻŦā§āϰ āĻāĻŋāĻāĻĄāĻŽ āĻĨā§āĻā§ āĻāĻāϤ āĻŽāĻŋ. āĻĢāϝāĻŧāϏāĻžāϞ āĻāϞ āĻāϤāĻžāĻāĻŦāĻŋ āϧā§āϰ⧠āϧā§āϰ⧠āĻĻā§āώā§āĻāĻŋāĻļāĻā§āϤāĻŋāϰ āϏāĻŽāϏā§āϝāĻžāϝāĻŧ āĻā§āĻāĻāĻŋāϞā§āύ, āϝāĻž āϤāĻžāĻāϰ āĻĻā§āύāύā§āĻĻāĻŋāύ āĻā§āĻŦāύ⧠āĻĒā§āϰāĻāĻžāĻŦ āĻĢā§āϞāϤ⧠āĻļā§āϰ⧠āĻāϰā§āĻāĻŋāϞāĨ¤ āĻāĻžāĻĒāϏāĻž āĻĻā§āώā§āĻāĻŋ..
āĻŽāĻŋ. āĻāϞāĻŋ āĻŽā§āĻšāϏā§āύ
Yemen
āĻŽāϧā§āϝāĻĒā§āϰāĻžāĻā§āϝā§āϰ 37 āĻŦāĻāϰ āĻŦāϝāĻŧāϏ⧠āϰā§āĻā§ āĻŽāĻŋ. āĻāϞāĻŋ āĻŽā§āĻšāϏā§āύ āĻāϞāĻļā§āĻāϝāĻŧāĻžāĻŦāĻŋ āĻĻā§āϰā§āĻāĻĻāĻŋāύ āϧāϰ⧠āϤā§āĻŦā§āϰ āĻā§āϝāĻŧāĻžāϞā§āϰ āĻŦā§āϝāĻĨāĻž, āĻŽā§āĻ āĻā§āϞāĻžāϰ āϏā§āĻŽāĻžāĻŦāĻĻā§āϧāϤāĻž, āĻāĻŋāĻŦāĻžāϤ⧠āĻ āϏā§āĻŦāĻŋāϧāĻž āĻāĻŦāĻ āĻĻā§āϰā§āĻāϏā§āĻĨāĻžāϝāĻŧā§ āĻā§āĻŽ..
āĻŽāĻŋ. āϏāĻžāϞā§āĻš āĻŽāĻžāϰāĻā§āĻ āĻāϞ āĻā§āϰāĻžāĻāĻļāĻŋ
Saudi Arabia
āϏā§āĻĻāĻŋ āĻāϰāĻŦā§āϰ āĻāĻŋāĻāĻĄāĻŽ āĻĨā§āĻā§ āĻāĻāϤ 65 āĻŦāĻāϰ āĻŦāϝāĻŧāϏ⧠āϰā§āĻā§ āĻŽāĻŋ. āϏāĻžāϞā§āĻš āĻŽāĻžāϰāĻā§āĻ āĻāϞ āĻā§āϰāĻžāĻāĻļāĻŋ āĻāĻāĻāĻŋ āϏāĻĄāĻŧāĻ āĻĻā§āϰā§āĻāĻāύāĻžāϰ āĻĒāϰ āĻā§āϰā§āϤāϰ āĻšāĻžāĻāĻā§āϰ āĻāĻāĻžāϤ⧠āĻāĻā§āϰāĻžāύā§āϤ āĻšāύāĨ¤ āĻāϞāĻžāĻāϞā§āϰ āϏāĻā§āώāĻŽāϤāĻž āĻĒā§āύāϰā§āĻĻ..
āĻŽāĻŋ. āĻāĻŦāĻĻā§āϞā§āϞāĻžāĻš āĻāϝāĻŧā§āĻĻ
Yemen
āĻāϝāĻŧā§āĻŽā§āύā§āϰ āĻŽāĻŋ. āĻāĻŦāĻĻā§āϞā§āϞāĻžāĻš āĻāϝāĻŧā§āĻĻ āĻŦāĻšā§ āĻŦāĻāϰ āϧāϰ⧠āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻāĻāύā§āϰ āϏāĻŽāϏā§āϝāĻžāϝāĻŧ āĻā§āĻāĻāĻŋāϞā§āύ, āϝāĻž āϧā§āϰ⧠āϧā§āϰ⧠āϤāĻžāĻāϰ āϏāĻžāĻŽāĻā§āϰāĻŋāĻ āϏā§āĻŦāĻžāϏā§āĻĨā§āϝ, āĻāϞāĻžāĻāϞ āĻāĻŦāĻ āĻĻā§āύāύā§āĻĻāĻŋāύ āĻā§āĻŦāύāĻŽāĻžāύā§āϰ āĻāĻĒāϰ āĻĒā§āϰ..
āĻŽāĻŋ. āϏāĻžāĻĻ āĻāϝāĻŧāĻžāĻšāĻāϝāĻŧāĻž āĻāϞ āĻāϏāϞāĻžāĻ
Saudi Arabia
āĻŽāĻŋ. āϏāĻžāĻĻ āĻāϝāĻŧāĻžāĻšāĻāϝāĻŧāĻž āĻāϞ āĻāϏāϞāĻžāĻ, āϏā§āĻĻāĻŋ āĻāϰāĻŦā§āϰ āĻāĻŋāĻāĻĄāĻŽ āĻĨā§āĻā§, āĻĻā§āϰā§āĻāĻĻāĻŋāύ āϧāϰ⧠āϏā§āĻĨāĻžāϝāĻŧā§ āĻšāĻāĻŽāĻāύāĻŋāϤ āϏāĻŽāϏā§āϝāĻžāϝāĻŧ āĻā§āĻāĻāĻŋāϞā§āύāĨ¤ āĻāύ āĻāύ āĻ āĻŽā§āϞāϤāĻž, āϤā§āĻŦā§āϰ āĻā§āϝāĻžāϏā§āĻā§āϰā§āĻāϏā§āĻĢā§āĻāĻŋāϝāĻŧāĻžāϞ āϰāĻŋāĻĢā§āϞāĻžāĻā§āϏ..
āĻŽāĻŋ. āĻāϞāϰāĻžāĻļā§āĻĻ āĻāϞāϤāĻžāϝāĻŧā§āĻŦ āĻŽā§āĻšāĻžāĻŽā§āĻŽāĻĻ
Sudan
āĻŽāĻŋ. āĻāϞāϰāĻžāĻļā§āĻĻ āĻāϞāϤāĻžāϝāĻŧā§āĻŦ āĻŽā§āĻšāĻžāĻŽā§āĻŽāĻĻ, āϏā§āĻĻāĻžāύ āĻĨā§āĻā§, āĻĻā§āϰā§āĻāĻĻāĻŋāύ āϧāϰ⧠āϏā§āĻĨāĻžāϝāĻŧā§ āĻĄā§āύā§āĻāĻžāϞ āϏāĻŽāϏā§āϝāĻžāϰ āĻŽā§āĻā§āĻŽā§āĻāĻŋ āĻšāĻā§āĻāĻŋāϞā§āύ, āϝāĻž āϤāĻžāϰ āĻāϰāĻžāϞ āĻšā§āϞāĻĨ, āĻā§āĻšāĻžāϰāĻž āĻāĻŦāĻ āĻāϤā§āĻŽāĻŦāĻŋāĻļā§āĻŦāĻžāϏāĻā§ āĻāϞā§āϞā§āĻāϝā§..
āĻŽāĻŋāϏ āĻŽā§āĻāĻž āĻŽā§āĻšāĻžāĻŽā§āĻŽāĻĻ
Oman
āĻŽāĻŋāϏ āĻŽā§āĻāĻž āĻŽā§āĻšāĻžāĻŽā§āĻŽāĻĻ, āĻāĻŽāĻžāύ āĻĨā§āĻā§, āĻā§āϰā§āϤāϰ āϏā§āύāĻžāϝāĻŧā§āĻŦāĻŋāĻ āĻāĻĒāϏāϰā§āĻā§āϰ āϏāĻŽā§āĻŽā§āĻā§āύ āĻšāĻā§āĻāĻŋāϞā§āύ, āϝāĻž āϧā§āϰ⧠āϧā§āϰ⧠āϤāĻžāϰ āĻĻā§āύāύā§āĻĻāĻŋāύ āĻāĻžāϰā§āϝāĻā§āϰāĻŽ, āĻļāĻžāϰā§āϰāĻŋāĻ āĻļāĻā§āϤāĻŋ āĻāĻŦāĻ āϏāĻžāĻŽāĻā§āϰāĻŋāĻ āĻā§āĻŦāύāĻŽāĻžāύāĻā§..